Login is disabled for site maintenance during the period: 14:00 - 16:00 GMT/UTC, 2024-09-24

Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia

Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )

Ibrutinib as a frontline therapy in RESONATE2 trials for CLL

Prof Jan Burger, MD Anderson Cancer Center, Texas, USA

Ibrutinib as a frontline therapy in RESONATE2 trials for CLL ( Prof Jan Burger, MD Anderson Cancer Center, Texas, USA )

The role of the microenvironment and novel therapies in CLL

Prof Jan Burger - MD Anderson Cancer Center, Texas, USA

The role of the microenvironment and novel therapies in CLL ( Prof Jan Burger - MD Anderson Cancer Center, Texas, USA )

p62: Metabolism and the tumour microenvironment

Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La...

p62: Metabolism and the tumour microenvironment ( Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA )

Targeted therapy shows continued promise in patients whose tumours had NTRK...

Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA

Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions ( Dr David Hong - University of Texas MD Anderson Cancer Center, Houston, USA )

Drugging “undruggable” transcription factor drivers in cancer

Dr John Bushweller - Unviersity of Virgina, Virginia, USA

Drugging “undruggable” transcription factor drivers in cancer ( Dr John Bushweller - Unviersity of Virgina, Virginia, USA )

Combination therapy before surgery improves outcomes for patients with HER2...

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania...

Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )

Elucidation and pharmacological targeting of tumour checkpoint dependencies

Dr Andrea Califano - Colombia University Medical Centre, New York, USA

Elucidation and pharmacological targeting of tumour checkpoint dependencies ( Dr Andrea Califano - Colombia University Medical Centre, New York, USA )

Identifying myeloid-driven biologies

Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA

Identifying myeloid-driven biologies ( Dr Brian Ruffell - Moffitt Cancer Center, Tampa, USA )

Metastasis intiation mediated by thrombospondin 2

Dr Ilaria Malanchi - Crick Institute, London, UK

Metastasis intiation mediated by thrombospondin 2 ( Dr Ilaria Malanchi - Crick Institute, London, UK )

New technology can potentially overcome CAR T-cell limitations

Dr Philip Low - Purdue University, West Lafayette, USA

New technology can potentially overcome CAR T-cell limitations ( Dr Philip Low - Purdue University, West Lafayette, USA )

AML17 Trial results: maximum dosage of daunorubicin in AML

Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK

AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )

More from ecancer